Clara A Agutu1, Tony H Oduor1, Bernadette K Kombo1, Peter M Mugo1, Salome M Chira1, Fred W Ogada1, Tobias F Rinke de Wit2, Wairimu Chege3, Elise M van der Elst1, Susan M Graham1,4, Eduard J Sanders1,2,5. 1. Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya. 2. Department of Global Health, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands. 3. Prevention Sciences Program, Division of AIDS (DAIDS), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, Maryland, United States of America. 4. Departments of Global Health, Medicine, and Epidemiology, University of Washington, Seattle, Washington, United States of America. 5. Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Abstract
BACKGROUND: Only approximately one in five adults are offered HIV testing by providers when seeking care for symptoms of acute illness in Sub-Saharan Africa. Our aims were to estimate testing coverage and identify predictors of provider-initiated testing and counselling (PITC) and barriers to PITC implementation in this population. METHODS: We assessed HIV testing coverage among adult outpatients 18-39 years of age at four public and two private health facilities in coastal Kenya, during a 3- to 6-month surveillance period at each facility. A subset of patients who reported symptoms including fever, diarrhoea, fatigue, body aches, sore throat or genital ulcers were enrolled to complete a questionnaire independently of PITC offer. We assessed predictors of PITC in this population using generalised estimating equations and identified barriers to offering PITC through focus group discussion with healthcare workers (HCW) at each facility. RESULTS: Overall PITC coverage was 13.7% (1600 of 11,637 adults tested), with 1.9% (30) testing positive. Among 1,374 participants enrolled due to symptoms, 378 (27.5%) were offered PITC and 352 (25.6%) were tested, of whom 3.7% (13) tested positive. Among participants offered HIV testing, 93.1% accepted it; among participants not offered testing, 92.8% would have taken an HIV test if offered. The odds of completed PITC were increased among older participants (adjusted odds ratio [aOR] 1.7, 95% confidence interval [CI] 1.4-2.1 for 30-39 years, relative to 18-24 years), men (aOR 1.3, 95% CI 1.1-1.7); casual labourers (aOR 1.3, 95% CI 1.0-1.7); those paying by cash (aOR 1.2, 95% CI 1.0-1.4) or insurance (aOR 3.0, 95% CI 1.5-5.8); participants with fever (aOR 1.5, 95% CI 1.2-1.8) or genital ulcers (aOR 4.0, 95% CI 2.7-6.0); and who had tested for HIV >1 year ago (aOR 1.4, 95% CI 1.0-2.0) or had never tested (aOR 2.2, 95% CI 1.5-3.1). Provider barriers to PITC implementation included lack of HCW knowledge and confidence implementing guidelines, limited capacity and health systems constraints. CONCLUSION: PITC coverage was low, though most patients would accept testing if offered. Missed opportunities to promote testing during care-seeking were common and innovative solutions are needed.
BACKGROUND: Only approximately one in five adults are offered HIV testing by providers when seeking care for symptoms of acute illness in Sub-Saharan Africa. Our aims were to estimate testing coverage and identify predictors of provider-initiated testing and counselling (PITC) and barriers to PITC implementation in this population. METHODS: We assessed HIV testing coverage among adult outpatients 18-39 years of age at four public and two private health facilities in coastal Kenya, during a 3- to 6-month surveillance period at each facility. A subset of patients who reported symptoms including fever, diarrhoea, fatigue, body aches, sore throat or genital ulcers were enrolled to complete a questionnaire independently of PITC offer. We assessed predictors of PITC in this population using generalised estimating equations and identified barriers to offering PITC through focus group discussion with healthcare workers (HCW) at each facility. RESULTS: Overall PITC coverage was 13.7% (1600 of 11,637 adults tested), with 1.9% (30) testing positive. Among 1,374 participants enrolled due to symptoms, 378 (27.5%) were offered PITC and 352 (25.6%) were tested, of whom 3.7% (13) tested positive. Among participants offered HIV testing, 93.1% accepted it; among participants not offered testing, 92.8% would have taken an HIV test if offered. The odds of completed PITC were increased among older participants (adjusted odds ratio [aOR] 1.7, 95% confidence interval [CI] 1.4-2.1 for 30-39 years, relative to 18-24 years), men (aOR 1.3, 95% CI 1.1-1.7); casual labourers (aOR 1.3, 95% CI 1.0-1.7); those paying by cash (aOR 1.2, 95% CI 1.0-1.4) or insurance (aOR 3.0, 95% CI 1.5-5.8); participants with fever (aOR 1.5, 95% CI 1.2-1.8) or genital ulcers (aOR 4.0, 95% CI 2.7-6.0); and who had tested for HIV >1 year ago (aOR 1.4, 95% CI 1.0-2.0) or had never tested (aOR 2.2, 95% CI 1.5-3.1). Provider barriers to PITC implementation included lack of HCW knowledge and confidence implementing guidelines, limited capacity and health systems constraints. CONCLUSION: PITC coverage was low, though most patients would accept testing if offered. Missed opportunities to promote testing during care-seeking were common and innovative solutions are needed.
Authors: Lisa M Bebell; Christopher D Pilcher; Grant Dorsey; Diane Havlir; Moses R Kamya; Michael P Busch; Joan Dunn Williams; Charles T Nugent; Christopher Bentsen; Philip J Rosenthal; Edwin D Charlebois Journal: AIDS Date: 2010-07-31 Impact factor: 4.177
Authors: Felix R Kayigamba; Daniëla Van Santen; Mirjam I Bakker; Judith Lammers; Veronicah Mugisha; Emmanuel Bagiruwigize; Ludwig De Naeyer; Anita Asiimwe; Maarten F Schim Van Der Loeff Journal: BMC Infect Dis Date: 2016-01-25 Impact factor: 3.090
Authors: Eduard J Sanders; Elizabeth Wahome; Kimberly A Powers; Lisa Werner; Greg Fegan; Ludo Lavreys; Clement Mapanje; R Scott McClelland; Nigel Garrett; William C Miller; Susan M Graham Journal: AIDS Date: 2015-12 Impact factor: 4.177
Authors: Peter M Macharia; Emanuele Giorgi; Abdisalan M Noor; Ejersa Waqo; Rebecca Kiptui; Emelda A Okiro; Robert W Snow Journal: Malar J Date: 2018-09-26 Impact factor: 2.979
Authors: Anne Ng'ang'a; Wanjiru Waruiru; Carol Ngare; Victor Ssempijja; Thomas Gachuki; Inviolata Njoroge; Patricia Oluoch; Davies O Kimanga; William K Maina; Rex Mpazanje; Andrea A Kim Journal: J Acquir Immune Defic Syndr Date: 2014-05-01 Impact factor: 3.731
Authors: Elise M van der Elst; Mitchelle Abuna; Clara Agutu; Fred Ogada; Aisha Galole; Joyce Shikuku; Tony Oduor; Susan M Graham; Eduard J Sanders; Don Operario Journal: PLoS One Date: 2022-01-13 Impact factor: 3.752
Authors: Clara A Agutu; Tony H Oduor; Amin S Hassan; Peter M Mugo; Wairimu Chege; Tobias F Rinke de Wit; Eduard J Sanders; Susan M Graham Journal: BMC Public Health Date: 2022-02-11 Impact factor: 3.295
Authors: Eduard J Sanders; Clara Agutu; Elise van der Elst; Amin Hassan; Evanson Gichuru; Peter Mugo; Carey Farquhar; Joseph B Babigumira; Steven M Goodreau; Deven T Hamilton; Thumbi Ndung'u; Martin Sirengo; Wairimu Chege; Susan M Graham Journal: HIV Med Date: 2021-08-25 Impact factor: 3.094
Authors: Brooke E Nichols; Alexandra de Nooy; Mariet Benade; Kelvin Balakasi; Misheck Mphande; Gabriella Rao; Cassidy W Claassen; Shaukat Khan; Christian Stillson; Colin A Russell; Naoko Doi; Kathryn Dovel Journal: J Int AIDS Soc Date: 2022-10 Impact factor: 6.707
Authors: Joseph B Babigumira; Clara A Agutu; Deven T Hamilton; Elise van der Elst; Amin Hassan; Evanson Gichuru; Peter Mwangi Mugo; Carey Farquhar; Thumbi Ndung'u; Martin Sirengo; Wairimu Chege; Steven M Goodreau; Eduard J Sanders; Susan M Graham Journal: BMJ Open Date: 2022-09-29 Impact factor: 3.006
Authors: Steven Wambua; Lucas Malla; George Mbevi; Joel Kandiah; Amen-Patrick Nwosu; Timothy Tuti; Chris Paton; Bernard Wambu; Mike English; Emelda A Okiro Journal: BMJ Open Date: 2022-03-10 Impact factor: 2.692